<DOC>
	<DOCNO>NCT00077311</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy , docetaxel cisplatin , work different way stop tumor cell divide stop grow die . Chemoprotective drug , dimesna , may help prevent decrease side effect ( nerve , kidney , inner ear damage ) cause chemotherapy . PURPOSE : This randomized phase II trial study give docetaxel cisplatin together dimesna see well work compare give docetaxel cisplatin alone treat patient stage IIIB stage IV non-small cell lung cancer .</brief_summary>
	<brief_title>Docetaxel Cisplatin With Without Dimesna Treating Patients With Stage IIIB Stage IV Non-Small Cell Lung Cancer</brief_title>
	<detailed_description>OBJECTIVES : Primary - Compare incidence severity peripheral neuropathy patient stage IIIB IV non-small cell lung cancer treat docetaxel cisplatin without dimesna . - Compare feasibility regimen , term febrile neutropenia treatment delay , patient . - Compare objective response rate patient treat regimen . Secondary - Compare survival failure-free survival patient treat regimen . - Compare toxicity profile regimens patient . - Compare incidence severity cisplatin-induced nephrotoxicity patient treat regimen . OUTLINE : This randomize , multicenter study . Patients randomize 1 2 treatment arm . - Arm I* : Patients receive docetaxel IV 1 hour cisplatin IV 1 hour day 1 pegfilgrastim subcutaneously ( SC ) day 2 . - Arm II* : Patients receive docetaxel , cisplatin , pegfilgrastim arm I dimesna IV 30 minute day 1 . NOTE : *In arm , darbepoetin alfa administer SC day 1 course hemoglobin ≤ 11 g/dL . In arm , treatment repeat every 2 week total 6 course absence disease progression unacceptable toxicity . Patients follow every 3 month 1 year every 6 month 2 year .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Neutropenia</mesh_term>
	<mesh_term>Docetaxel</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Darbepoetin alfa</mesh_term>
	<mesh_term>Mesna</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically cytologically confirmed* nonsmall cell lung cancer 1 follow subtypes : Squamous carcinoma Basaloid carcinoma Adenocarcinoma Bronchoalveolar carcinoma Adenosquamous carcinoma Large cell carcinoma Large cell neuroendocrine carcinoma Giant cell carcinoma Sarcomatoid carcinoma Nonsmall cell carcinoma otherwise specified NOTE : *Histologic cytologic confirmation recurrence require patient undergone prior complete resection Stage IIIB disease due malignant pleural effusion OR stage IV disease Measurable disease At least 1 unidimensionally measurable lesion least 20 mm conventional technique OR least 10 mm spiral CT scan The following consider nonmeasurable disease : Bone lesion Brain metastasis leptomeningeal disease Ascites Pleural/pericardial effusion Abdominal mass confirm followed imaging technique Cystic lesion Tumor lesion situate previously irradiate area Brain metastasis allow provided patient neurologically stable steroid PATIENT CHARACTERISTICS : Age 18 Performance status ECOG 01 Life expectancy Not specify Hematopoietic Granulocyte count ≥ 1,500/mm^3 Platelet count ≥ 100,000/mm^3 Hepatic Bilirubin ≤ 1.5 mg/dL AST ≤ 1.5 time upper limit normal ( ULN ) Alkaline phosphatase ≤ 2.5 time ULN Renal Creatinine ≤ ULN Other Not pregnant nursing Fertile patient must use effective contraception No grade 2 great neuropathy PRIOR CONCURRENT THERAPY : Biologic therapy No concurrent growth factor Chemotherapy No prior chemotherapy No concurrent chemotherapy Endocrine therapy See Disease Characteristics No concurrent hormonal therapy except steroid administer adrenal failure , hormone noncancerrelated condition ( e.g. , insulin diabetes ) , intermittent dexamethasone antiemetic Radiotherapy See Disease Characteristics Prior radiotherapy allow brain metastasis No concurrent palliative radiotherapy Surgery See Disease Characteristics</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>120 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>drug/agent toxicity tissue/organ</keyword>
	<keyword>anemia</keyword>
	<keyword>neutropenia</keyword>
	<keyword>stage IV non-small cell lung cancer</keyword>
	<keyword>stage IIIB non-small cell lung cancer</keyword>
	<keyword>recurrent non-small cell lung cancer</keyword>
	<keyword>squamous cell lung cancer</keyword>
	<keyword>large cell lung cancer</keyword>
	<keyword>adenocarcinoma lung</keyword>
	<keyword>bronchoalveolar cell lung cancer</keyword>
	<keyword>adenosquamous cell lung cancer</keyword>
</DOC>